1. Home
  2. SLE vs SCNI Comparison

SLE vs SCNI Comparison

Compare SLE & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Super League Enterprise Inc.

SLE

Super League Enterprise Inc.

HOLD

Current Price

$0.51

Market Cap

3.1M

ML Signal

HOLD

SCNI

Scinai Immunotherapeutics Ltd.

HOLD

Current Price

$0.85

Market Cap

2.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLE
SCNI
Founded
2014
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1M
2.6M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
SLE
SCNI
Price
$0.51
$0.85
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
262.2K
34.8K
Earning Date
11-13-2025
03-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.26
Revenue
$11,568,000.00
$1,147,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$20.37
N/A
P/E Ratio
N/A
$3.28
Revenue Growth
N/A
303.87
52 Week Low
$0.53
$0.61
52 Week High
$26.00
$6.18

Technical Indicators

Market Signals
Indicator
SLE
SCNI
Relative Strength Index (RSI) 34.90 48.47
Support Level $0.62 $0.78
Resistance Level $0.76 $0.96
Average True Range (ATR) 0.08 0.07
MACD 0.02 0.02
Stochastic Oscillator 9.11 56.47

Price Performance

Historical Comparison
SLE
SCNI

About SLE Super League Enterprise Inc.

Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn, and create. The company offers a complete range of development, distribution, monetization, and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising, including immersive game world and experience publishing and in-game media products, direct-to-consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

Share on Social Networks: